ERCC1 mRNA Levels Can Predict the Response to Cisplatin-Based Concurrent Chemoradiotherapy of Locally Advanced Cervical Squamous Cell Carcinoma

Radiation Oncology - United Kingdom
doi 10.1186/1748-717x-7-221
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC


Related search